Health Invest Partners Ab Kempharm, Inc Transaction History

Health Invest Partners Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.12 - $5.62 $1.73 Million - $2.36 Million	-420,000 Reduced 56.0%	330,000 $1.51 Million
Q3 2022 Oct 21, 2022	BUY	$4.5 - $6.85 $360,000 - $548,000	80,000 Added 11.94%	750,000 $4.68 Million
Q2 2022 Jul 08, 2022	BUY	$4.02 - $5.21 $1.67 Million - $2.16 Million	415,000 Added 162.75%	670,000 $2.99 Million
Q1 2022 May 05, 2022	BUY	$5.0 - $9.26 $1.28 Million - $2.36 Million	255,000 New	255,000 $1.28 Million

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.